1. News | 2016.08.28

   Alzheimer's: nicotinic receptors as a new therapeutic target

   Several scientific studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attributed to nicotine – which is known to have an adverse effect on health – by determining the precise structure of the nicotinic receptors in the hippocampus region of the brain. Using mouse...

2. News | 2015.01.07

   #JeSuisCharlie

   In this day of National Mourning, the Institut Pasteur expresses its deep sadness and supports all people and families affected by this tragedy. #JeSuisCharlie

3. News | 2015.01.08

   Resident and recruited macrophages orchestrate the liver's defense against infection

   Scientists have demonstrated that liver-resident macrophages are rapidly killed by the pathogenic bacterium Listeria monocytogenes. This early death triggers the recruitment of macrophages from the bloodstream to the liver. These macrophages start by bringing the bacterial infection under control; then, in an unexpected development, they actually replace the liver-resident macrophages that have...

4. News | 2015.01.13

   Identification of an Achilles heel in the dengue virus gives new hope for vaccine development

   Scientists have identified a vulnerable site on the surface of the dengue virus which is targeted by the only broadly neutralizing antibodies identified to date. This discovery offers a new target for the development of a vaccine to combat all four types of dengue virus currently in circulation.

5. News | 2015.01.18

   Pasteur International Joint Research Units

   Institut Pasteur is launching an International Call for Proposals for the creation of Pasteur International Joint Research Units within the Institut Pasteur International Network (RIIP), and within host institutions outside the RIIP.   Who can apply? Researchers from Institut Pasteur in Paris, researchers from the Institut Pasteur International Network or,  from international research...

6. News | 2015.01.18

   Segmented filamentous bacteria, partners in intestinal immunity, finally cultured in vitro

   Despite the vital role of segmented filamentous bacteria in establishing gut immune homeostasis in vivo in mice, scientists, for the past 50 years, have been unable to reproduce this symbiosis in vitro to shed light on the cellular and molecular interactions involved. Now, scientists have successfully cultured and reproduced the complex life-cycle of these bacteria outside their host for the...

7. News | 2015.01.15

   The biological basis of good health

   In a biological sense, what does it mean to be “in good health”? This far-reaching question is the focus of the “Laboratoire d'Excellence” project Milieu Intérieur (“Environment Within”). The Milieu Intérieur cohort is the first French cohort of its kind, comprised of a thousand healthy donors. Studying this cohort will help define the parameters of a...

8. News | 2015.01.22

   Ebola: Study of the chains of transmission in Conakry

   Researchers at the Institut Pasteur of Dakar and the Institut Pasteur in Paris have reconstructed chains of transmission of Ebola virus in the capital city of Guinea, from February to August 2014. The data show the positive impact of control measures on the evolution of the epidemic but highlight the challenges of Ebola control in large urban centres.

9. News | 2015.01.26

   Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases

   For 10 years, Total and its corporate foundation working alongside the Institut Pasteur and its International Network in the fight against infectious diseases. A new sponsorship agreement, of EUR 6 million for three years, was signed on 26 January 2015. It will provide funding, for public health and research projects in resource limited countries in order to better understand the therapeutic and...

10. News | 2015.02.02

    Moderna and Institut Pasteur Sign Strategic Research Collaboration

    Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, today announced a long-term strategic research collaboration for the discovery and development of drugs and vaccines using Moderna’s mRNA Therapeutics™ platform. Valera, a Moderna venture company, will manage the research collaboration for Moderna.

Pages